nanaomycin E

epoxy deriv of nanaomycin A; see also nanaomycin A: 52934-83-5, nanaomycin B: 52934-85-7, nanaomycin C: 58286-55-8; RN in 9th CI for nanaomycin D: 60325-08-8; structure in first source

Also Known As:

4a,10a-Epoxy-1H-naphtho(2,3-c)pyran-3-acetic acid, 3,4,5,10-tetrahydro-9-hydroxy-1-methyl-5,10-dioxo-, (1S-(1alpha,3beta,4abeta,10abeta))-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Funatsu, Takashi: 1 article (01/2022)
2.	Harada, Yoshie: 1 article (01/2022)
3.	Ikoma, Kenta: 1 article (01/2022)
4.	Matsui, Yudai: 1 article (01/2022)
5.	Misawa, Takuma: 1 article (01/2022)
6.	Nakayama, Akiyoshi: 1 article (01/2022)
7.	Nishida, Shuhei: 1 article (01/2022)
8.	Noguchi, Yoshihiko: 1 article (01/2022)
9.	Pan, Yixi: 1 article (01/2022)
10.	Saitoh, Tatsuya: 1 article (01/2022)

Related Diseases

1.	Mitochondrial Diseases (Mitochondrial Disease) 01/01/2022 - "Nanaomycin E inhibits NLRP3 inflammasome activation by preventing mitochondrial dysfunction."
2.	Dehydration (Water Stress) 07/01/1980 - "Nanaomycin B can be converted to nanaomycin A by non-enzymatic dehydration; however, nanaomycin A is rapidly bioconverted to nanaomycin E, which is the major component synthesized by the nanaomycin-producing strain."

Related Drugs and Biologics

1.	Inflammasomes
2.	nanaomycin B
3.	nanaomycin A